News Focus
News Focus
icon url

theorysuit

06/30/24 11:29 AM

#702614 RE: exwannabe #702613

They haven't even started a commercialization plan. So of course there is not even any attempt to work on NICE. DILUTION to over 2b shares outstanding is the way. No BP in their right mind would work with this company. Stop this partnership nonsense carrot talk.....it's embarassing.


Serial mode for life. And please stop this BS multiple RAs. Long way to go with this one. Inspections, RFI, commercialization, and hiring contractors for NICE. Neverending story on this scam stock. What's another 3 years to get this all done
icon url

flipper44

06/30/24 11:39 AM

#702618 RE: exwannabe #702613

There are alternative interim funding methods after approval.
icon url

dennisdave

06/30/24 3:17 PM

#702682 RE: exwannabe #702613

You conveniently forget that after UK approval every GBM patient on the globe with money will flock to NWBO to get DCVAXL.
Every year globally, more than 300,000 cases of glioblastoma are diagnosed x 20% with the means to pay for the treatment = 60k ok 30k ok 10k ok 5k patients that will ring NWBO in 2025 x 200k = 1 billion revenue ok 500 million revenue ok 250 million ok $150 million in revenue ... in 2025

the point is NICE will not determine NWBO's revenue in 2025 the 300k patients worldwide will.
icon url

drugrunner

06/30/24 6:13 PM

#702736 RE: exwannabe #702613

Spoken like the true basher that you Rx, you know everything that Linda has to do is a process and it’s sequential. You have to follow the playbook that she has established. You are following your playbook and bashing every step of the way which you have done for the last 10 years Yesterday and today are no different. It will still be a process going forward whether approval happens within 3 to 6 months for the MHR and then we start to work on NICE.
Do you like to pretend that there will be zero revenues coming in upon approval that is patently false but you keep up the negative narrative that you’ve had for 10 years you won’t be proven wrong but the next day it is possible and likely